GPCRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Structure Therapeutics Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$22.01+0.93 (+4.41%)
Close on Oct 19, 2026
- Market cap
- $4.80B
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Structure Therapeutics has not reported a dividend
No dividend per share appears in Structure Therapeutics's annual filings since fiscal 2021.